CalciMedica, Inc. / Fundamentals
Income statement
- Net revenue
€0.00 - Cost of goods sold
€12.08K - Gross profit
€0.00 - SG&A expenses
€8.09M - R&D expenses
€13.51M - EBITDA
-€21.57M - D&A
€25.03K - EBIT
-€21.60M - Interest expenses
-€106.15K - EBT
-€18.02M - Tax expenses
€12.95K - Net income
-€18.02M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€10.51M - Changes in working capital
€536.81K - Operating cash flow
-€28.22M - Capex
€18.99K - Other investing cash flow
€0.00 - Net investing cash flow
€2.13M - Total cash dividends paid
€0.00 - Issuance of common stock
€24.09M - Debt repayment
€0.00 - Other financing cash flow
€25.62M - Net financing cash flow
€16.90M - Foreign exchange effects
€0.00 - Net change in cash
€743.94K - Cash at end of period
€5.11M - Free cash flow
-€28.20M
Balance sheet
- Cash and cash equivalents
€5.11M - Cash and short-term investments
€15.50M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€869.08K - Total current assets
€16.37M - Property, plant & equipment
€90.62K - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€9.49K - Total non-current assets
€100.11K - Total assets
€16.47M - Accounts payable
€1.65M - Short-term debt
€0.00 - Other current liabilities
€1.35M - Total current liabilities
€3.00M - Long-term debt
€0.00 - Deferred tax liabilities
€0.00 - Other non-current liabilities
€8.20M - Total non-current liabilities
€8.20M - Total liabilities
€11.20M - Common stock
€3.45K - Retained earnings
-€147.37M - Other equity
-€3.45K - Total equity
€5.27M - Total liabilities and shareholders' equity
€16.47M
Company information
- Market capitalization
€17.04M - Employees
14 - Enterprise Value
€12.73M
Company ratios
- Gross margin
-
0.0% - EBITDA margin
-
0.0% - EBIT margin
-
0.0% - EBT margin
-
0.0% - Net margin
-
0.0% - ROE
-
-342.0% - ROA
-
-109.4% - Asset turnover
-
0.0% - FCF margin
-
0.0% - FCF yield
-165.7% - Efficiency ratio
0.0% - Net sales per employee
-
€0.00 - Net income per employee
-
-€1.29M